HighGravityDataUnitedHealth Group — Apr 21, 2026 release
Fiscal 2026 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000731766-26-000121
Showing in the filing
Diluted earnings per share
“> $17.35”
Period
FY2026
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 12
Earnings outlook for FY2026
“Greater Than $17.35 Per Share”
Adjusted earnings outlook for FY2026
“Greater Than $18.25 Per Share”
Alegeus Technologies acquisition earnings im… for FY2026
“earnings neutral to 2026”
Share repurchase for Q2 FY2026
“at least $2 billion”
Long-term debt-to-capital ratio target for the long term
“approximately 40.0%”
Timing to reach long-term debt-to-capital ra… for the long term
“expects to reach that level in the back half of 2026”
Stock repurchase for Q2 FY2026
“at least $2.0 billion”
Projected 2026 expected reduction of loss co… for FY2026
“$402 million”
Net earnings attributable to UnitedHealth Gr… for FY2026
“> $15,800”
Adjusted net earnings attributable to United… for FY2026
“> $16,610”
Diluted earnings per share for FY2026
“> $17.35”
Adjusted diluted earnings per share for FY2026
“> $18.25”
Exhibit 99.1 · the passage around this item
… earlier in the release
(82) (102) ~(255) Adjusted net earnings attributable to UnitedHealth Group common shareholders ................................................... $6,578 $6,607 > $16,610 Diluted earnings per share ........................................................................................................................................................ $6.90 $6.85 > $17.35 Intangible amortization per share ............................................................................................................................................. 0.37 0.46 ~1.45 Net portfolio divestitures and South American impacts per share ..................................................................................... (0.17) — ~(0.05) Restructuring and other per share ........................................................................................................................................... 0.22 — ~(0.20) Tax effect of adjustments per share ......................................................................................................................................... (0.09) (0.11) ~(0.30) Adjusted diluted earnings per share ................................................................................................................................. $7.23 $7.20 > $18.25 End Notes (1) Net portfolio divestitures and South American impacts for the three months ended March 31, 2026 includes net gains on dispositions and businesses held for sale and $72 million of incremental losses related to South American businesses held for sale. For
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.